# AtriCure (ATRC) — Analyst Forecast

ATRC · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/atrc/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 7 | 3 | 0 | 10 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $50.00 | $58.80 | $64.00 | 5 |

Last price $57.78 (as of Oct 15, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Oct 12, 2026 | BTIG | Maintained | Buy | $63.00 |
| Oct 2, 2026 | Freedom Capital Markets | Downgraded | Buy → Hold | $57.00 |
| Sep 2, 2026 | Needham | Maintained | Buy | $64.00 |
| Aug 27, 2026 | Piper Sandler | Maintained | Overweight | $60.00 |
| Aug 24, 2026 | BTIG | Maintained | Buy | $55.00 |
| Jul 28, 2026 | UBS | Maintained | Buy | $50.00 |
| May 6, 2026 | Canaccord Genuity | Maintained | Buy | $55.00 |
| Feb 18, 2026 | Oppenheimer | Downgraded | Outperform → Perform | — |
| Feb 18, 2026 | UBS | Maintained | Buy | $55.00 |
| Feb 18, 2026 | BTIG | Maintained | Buy | $54.00 |
| Feb 18, 2026 | Canaccord Genuity | Maintained | Buy | $53.00 |
| Feb 18, 2026 | Citizens | Maintained | Market Outperform | $52.00 |
| Feb 12, 2026 | Needham | Maintained | Buy | $45.00 |
| Dec 16, 2025 | JP Morgan | Maintained | Overweight | $48.00 |
| Oct 30, 2025 | Canaccord Genuity | Maintained | Buy | $64.00 |
| Jul 30, 2025 | Needham | Maintained | Buy | $45.00 |
| Apr 30, 2025 | Needham | Maintained | Buy | $44.00 |
| Apr 30, 2025 | UBS | Maintained | Buy | $58.00 |
| Apr 30, 2025 | JMP Securities | Maintained | Market Outperform | $60.00 |
| Apr 2, 2025 | Citizens Capital Markets | Maintained | Market Outperform | $60.00 |

## Frequently Asked Questions

### What is the price target for ATRC stock?

The average 12-month analyst price target for AtriCure (ATRC) is $58.80, with a high estimate of $64.00 and a low of $50.00, across 5 analysts.

### Is ATRC a buy, sell, or hold?

Analysts covering AtriCure currently average a Buy rating: 7 buy, 3 hold and 0 sell, from 10 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for ATRC?

The average price target of $58.80 implies 1.77% upside from the last price of $57.78.

### What is the latest analyst rating on ATRC?

On Oct 12, 2026, BTIG maintained AtriCure at Buy with a price target of $63.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).